Background: Interest in pharmacist participation in the multidisciplinary intensive care team is increasing. However, studies examining pharmacist interventions in the medical intensive care unit (MICU) are limited in Korea. The aim of this study was to describe the current status of pharmacist interventions and to identify common pharmacologic problems requiring pharmacist intervention in the MICU. Methods: Between September 2013 and August 2014, a retrospective, observational study was conducted in the 22-bed MICU at a university hospital. Data were obtained from two trained pharmacists who participated in MICU rounds three times a week. In addition to patient characteristics, data on the cause, type, related drug, and acceptance rate of interventions were collected. Results: In 340 patients, a total of 1211 pharmacologic interventions were performed. The majority of pharmacologic interventions were suggested by pharmacists at multidisciplinary rounds in the MICU. The most common pharmacologic interventions were adjustment of dosage and administration (n = 328, 26.0%), followed by parenteral/enteral nutritional support (n = 228, 18.1%), the provision of drug information (n = 228, 18.1%), and advice regarding pharmacokinetics (n = 118, 9.3%). Antimicrobial agents (n = 516, 42.6%) were the most frequent type of drug associated with pharmacist interventions. The acceptance rate of interventions was 84.1% with most accepted by physicians within 24 hours (n = 602, 92.8%). Conclusions: Medication and nutritional problems are frequently encountered pharmacotherapeutic problems in the MICU. Pharmacist interventions play an important role in the management of these problems.
Introduction
Interest in the participation of pharmacists in multidisciplinary intensive care teams is increasing. It has been shown previously that pharmacist interventions have beneficial effects in critically ill patients, including in terms of reducing the incidence of medication errors and adverse drug events. [1] [2] [3] [4] Despite these beneficial effects, independent clinical pharmacy services in the intensive care unit (ICU) were adopted only recently in Korea. [5] Previously, studies of pharmacist interventions in surgical intensive care units (SICUs) were performed in Korea. [6] Kang et al. reported the prevalence, cause of adverse drug events, and types of pharmacist participation in a SICU. [6] Another study demonstrated the prevalence of adverse events and the current status of pharmacist interventions in a pediatric ICU. [7] However, studies examining the causes and types of pharmacist intervention in a medical intensive care unit (MICU) are rare in Korea. cc This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. Previous studies showed that MICU patient were older and had higher severity scores and higher fatality rates than SICU patients. [8] Although, few data directly compare pharmacist interventions in MICUs and SICUs, patients in MICUs need a higher rate of drug information services and total parenteral nutrition consultation than patients in SICUs. [5, 6, 9, 10] These differences influence clinical outcomes of MICU patients.
Therefore, considering the lack of pharmacologic data and aforementioned differences, it is necessary to investigate common drug errors and adverse drug events and pharmacist intervention in a MICU. This study describes the current status and implementation of clinical pharmacy services in a MICU. We evaluated pharmacist interventions and determined the prevalence of interventions and their cause, type, acceptance rate, and relevant medications.
Materials and Methods
We performed an observational study in the 22-bed MICU Table 1 . Of the 340 patients, 227 (66.8%) patients were male. The mean age of the patients was 66 years. The most common cause for admission to the ICU was respiratory failure (n = 198, 58.2%), followed by sepsis (n = 63, 18.5%). The majority of patients were admitted from the internal medicine department, specifically the respiratory and hematology-oncology divisions (n = 242, 71.2 %). 
Results
The vast majority of interventions were initiated by the pharmacist (n = 1179, 97.4%). The most common method of communication was the pharmacist's announcement at multidisciplinary rounds in the MICU (n = 1160, 95.2%). Other methods of communicating interventions were by phone (n = 31, 2.5%), by SMS (n = 19, 1.6%), via nurses (n = 8, 0.7%), and by EMR message service (n = 1, 0.1%).
The causes for intervention by a pharmacist are shown in The acceptance rates for interventions categorized by time course are shown in Table 3 . Physicians accepted 
84.1%).
The types of pharmacist interventions are shown in Table 4 .
Drug dosage and administration adjustment were the most common type of intervention recommended (n = 328,
26.0%). The provision of drug information and adjustment of PN/EN were both recommended for 228 cases (18.1%).
Other recommendations included pharmacokinetic advice (n = 118, 9.3%), suggestion to discontinue drugs (n = 99, 7.8%), suggestion to initiate drugs (n = 94, 7.4%), and alternative drug suggestions (n = 89, 7.0%).
The types of pharmacist intervention for each medical problem encountered in the MICU are shown in Table 5 .
The most frequent intervention for inappropriate dosage and administration was drug dosage adjustment (n = 294, 68.4%). The most common intervention for adverse drug reactions was the provision of drug information (n = 74, 50.0%), and the most common intervention for inappropriate drug selection was the recommendation of an alternative drug (n=53, 72.6%). Discontinuing the drug was the most frequently recommended intervention for drug duplication, inappropriate duration, and unnecessary drug usage.
The medications that most often required intervention
were anti-infective drugs (n = 516, 42.6%). PN/EN regimens (n = 256, 21.1%) required more interventions than other drugs (Fig. 1) . Vancomycin, colistimethate, and me- Table 5 . Cause of intervention and type of intervention recommended* ropenem were the drugs most frequently associated with intervention. The list of drugs associated with pharmacist intervention in more than 20 cases, excluding nutritional supplies, is shown in Fig. 2 .
Discussion
Pharmacist intervention in the ICU is increasing. Multiple drug therapy and the severity of disease among MICU patients result in many adverse drug events and prescription errors. [11, 12] It has been shown previously that pharmacist interventions are important in preventing those problems. In this study, the prevalence of intervention was 536 per 1,000 monitored patient days or an average of 3.3 recommendations per patient evaluated by pharmacists. Actually, the intervention rate among studies is quite different. In previous studies, restricted items mainly associated with patient safety, such as medication errors or adverse drug events, were reported. [2, 9, 12, 15] However, in this study,
we described all of the interventions that pharmacy services can offer, including the prevention of medication errors and adverse drug events, adverse drug reactions already encountered, refinements to nutritional regimens, and the provision of drug information. In addition, differences in classification and documentation of interventions might explain the differences in observed intervention incidence rates.
The rate of intervention acceptance in our study group
was similar to what has been reported previously. [2, 6, 15] The acceptance rate was more than 80%, indicating that pharmacist interventions were well accepted by physicians.
In addition, more than 90% of the pharmacist recommendations were accepted within 24 hours, which is higher than what was reported for the SICU. Pharmacists frequently changed antimicrobial drugs, nutritional products, and central-nervous-system-related drugs.
It has been shown previously that antibiotics are the drugs most commonly associated with prescription errors. [9, 10, 18] The high prevalence of infection in MICU patients could explain the high intervention rate. Pharmacists also made recommendations for other items, including cardiovascular therapy and fluid or electrolyte imbalance management.
The role pharmacists play in those cases is in the safe use of drugs and the notification of possible adverse drug reactions. [19] This study has a few limitations. It was conducted at a single center retrospectively. In addition, this study examined To our knowledge, this is the first study to investigate pharmacist interventions in a MICU in Korea. This study provides insight into pharmacy services in the MICU system. The prescription of multiple complex medications can result in medication errors or adverse drug effects. Thus, the involvement of pharmacists to rationalize medication therapy in the MICU could improve drug efficacy and patient safety, as well as increase physicians' understanding of drugs.
